DK475389D0 - Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet - Google Patents
Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitetInfo
- Publication number
- DK475389D0 DK475389D0 DK475389A DK475389A DK475389D0 DK 475389 D0 DK475389 D0 DK 475389D0 DK 475389 A DK475389 A DK 475389A DK 475389 A DK475389 A DK 475389A DK 475389 D0 DK475389 D0 DK 475389D0
- Authority
- DK
- Denmark
- Prior art keywords
- monoclonal antibodies
- reducing heterogeneity
- heterogeneity
- reducing
- monoclonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25078688A | 1988-09-28 | 1988-09-28 | |
| US25078888A | 1988-09-28 | 1988-09-28 | |
| US25078788A | 1988-09-28 | 1988-09-28 | |
| US07/364,056 US5126250A (en) | 1988-09-28 | 1989-06-09 | Method for the reduction of heterogeneity of monoclonal antibodies |
| CA000613379A CA1332367C (en) | 1988-09-28 | 1989-09-26 | Method for the reduction of heterogeneity of monoclonal antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK475389D0 true DK475389D0 (da) | 1989-09-27 |
| DK475389A DK475389A (da) | 1990-03-29 |
Family
ID=27508376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK475389A DK475389A (da) | 1988-09-28 | 1989-09-27 | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0361902B1 (da) |
| JP (1) | JP2925181B2 (da) |
| CN (1) | CN1041392A (da) |
| AR (1) | AR242986A1 (da) |
| AT (1) | ATE101876T1 (da) |
| AU (1) | AU615576B2 (da) |
| BG (1) | BG60017B2 (da) |
| CA (1) | CA1332367C (da) |
| DE (1) | DE68913251T2 (da) |
| DK (1) | DK475389A (da) |
| ES (1) | ES2049332T3 (da) |
| IE (1) | IE63562B1 (da) |
| IL (1) | IL91778A (da) |
| MX (1) | MX170441B (da) |
| NZ (1) | NZ230786A (da) |
| PL (1) | PL162260B1 (da) |
| RO (1) | RO105652B1 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2892925T3 (es) | 2006-03-31 | 2022-02-07 | Chugai Pharmaceutical Co Ltd | Métodos para controlar la farmacocinética en sangre de anticuerpos |
| EP1878747A1 (en) | 2006-07-11 | 2008-01-16 | greenovation Biotech GmbH | Glyco-engineered antibodies |
| EP2031064A1 (de) * | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
| CN101874042B9 (zh) | 2007-09-26 | 2019-01-01 | 中外制药株式会社 | 利用cdr的氨基酸取代来改变抗体等电点的方法 |
| AU2008304748C1 (en) | 2007-09-26 | 2014-06-12 | Chugai Seiyaku Kabushiki Kaisha | Modified antibody constant region |
| KR102057826B1 (ko) | 2008-04-11 | 2019-12-20 | 추가이 세이야쿠 가부시키가이샤 | 복수 분자의 항원에 반복 결합하는 항원 결합 분자 |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| TWI682995B (zh) | 2009-03-19 | 2020-01-21 | 日商中外製藥股份有限公司 | 抗體恆定區域改變體 |
| WO2010107110A1 (ja) | 2009-03-19 | 2010-09-23 | 中外製薬株式会社 | 抗体定常領域改変体 |
| TWI812066B (zh) | 2010-11-30 | 2023-08-11 | 日商中外製藥股份有限公司 | 具有鈣依存性的抗原結合能力之抗體 |
| JP6001456B2 (ja) * | 2010-12-28 | 2016-10-05 | 中外製薬株式会社 | 動物細胞の培養方法 |
| CN110563850A (zh) | 2012-04-30 | 2019-12-13 | 比奥孔有限公司 | 靶向/免疫调节性融合蛋白及其制造方法 |
| CA3081073C (en) * | 2013-03-12 | 2023-09-12 | Biocon Ltd. | Fusion immunomodulatory proteins and methods for making same |
| EP3009518B1 (en) | 2013-06-11 | 2020-08-12 | National Center of Neurology and Psychiatry | Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (rrms) patient, and method for determining applicability of novel therapy |
| JP6130983B2 (ja) | 2015-02-27 | 2017-05-17 | 中外製薬株式会社 | Ｉｌ−６関連疾患治療用組成物 |
| JP6875683B2 (ja) | 2015-05-19 | 2021-05-26 | 国立研究開発法人国立精神・神経医療研究センター | 多発性硬化症（ｍｓ）患者の新規治療適用判断方法 |
| PT3500586T (pt) * | 2016-10-17 | 2021-06-17 | Enzene Biosciences Ltd | Processo contínuo para reduzir a heterogeneidade da proteína terapêutica |
| EP3620531A4 (en) | 2017-05-02 | 2021-03-17 | National Center of Neurology and Psychiatry | METHOD OF PREDICTION AND EVALUATION OF THERAPEUTIC EFFECT IN DISEASES RELATING TO IL-6 AND NEUTROPHILS |
| EP3698808B1 (en) | 2017-10-20 | 2025-01-01 | Hyogo College Of Medicine | Anti-il-6 receptor antibody-containing medicinal composition for preventing post-surgical adhesion |
| WO2019151418A1 (ja) | 2018-01-31 | 2019-08-08 | 元一 加藤 | Ｉｌ－６阻害剤を含有する喘息の治療剤 |
| IL287220B2 (en) | 2019-04-17 | 2026-03-01 | Univ Hiroshima | A therapeutic agent for urological cancer characterized by administering an IL-6 inhibitor in combination with a CCR2 inhibitor |
| AU2021278562A1 (en) | 2020-05-29 | 2022-12-01 | Chugai Seiyaku Kabushiki Kaisha | Antibody-containing formulation |
-
1989
- 1989-09-26 CA CA000613379A patent/CA1332367C/en not_active Expired - Fee Related
- 1989-09-26 NZ NZ230786A patent/NZ230786A/xx unknown
- 1989-09-26 BG BG089846A patent/BG60017B2/bg unknown
- 1989-09-26 AR AR89310004A patent/AR242986A1/es active
- 1989-09-26 RO RO141765A patent/RO105652B1/ro unknown
- 1989-09-26 IL IL9177889A patent/IL91778A/en not_active IP Right Cessation
- 1989-09-27 PL PL89281598A patent/PL162260B1/pl unknown
- 1989-09-27 EP EP89309851A patent/EP0361902B1/en not_active Expired - Lifetime
- 1989-09-27 AU AU42343/89A patent/AU615576B2/en not_active Ceased
- 1989-09-27 IE IE309489A patent/IE63562B1/en not_active IP Right Cessation
- 1989-09-27 DK DK475389A patent/DK475389A/da not_active Application Discontinuation
- 1989-09-27 AT AT89309851T patent/ATE101876T1/de not_active IP Right Cessation
- 1989-09-27 ES ES89309851T patent/ES2049332T3/es not_active Expired - Lifetime
- 1989-09-27 MX MX017721A patent/MX170441B/es unknown
- 1989-09-27 DE DE68913251T patent/DE68913251T2/de not_active Expired - Fee Related
- 1989-09-28 CN CN89107508.9A patent/CN1041392A/zh active Pending
- 1989-09-28 JP JP1256890A patent/JP2925181B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL91778A (en) | 1994-10-07 |
| NZ230786A (en) | 1991-11-26 |
| BG60017B2 (bg) | 1993-06-30 |
| IE893094L (en) | 1990-03-28 |
| AU615576B2 (en) | 1991-10-03 |
| AU4234389A (en) | 1990-04-05 |
| EP0361902A2 (en) | 1990-04-04 |
| CN1041392A (zh) | 1990-04-18 |
| PL162260B1 (pl) | 1993-09-30 |
| JPH02163096A (ja) | 1990-06-22 |
| JP2925181B2 (ja) | 1999-07-28 |
| AR242986A1 (es) | 1993-06-30 |
| EP0361902A3 (en) | 1990-08-16 |
| CA1332367C (en) | 1994-10-11 |
| ES2049332T3 (es) | 1994-04-16 |
| IE63562B1 (en) | 1995-05-17 |
| DE68913251D1 (de) | 1994-03-31 |
| MX170441B (es) | 1993-08-23 |
| EP0361902B1 (en) | 1994-02-23 |
| ATE101876T1 (de) | 1994-03-15 |
| DE68913251T2 (de) | 1994-06-23 |
| DK475389A (da) | 1990-03-29 |
| RO105652B1 (ro) | 1992-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK475389D0 (da) | Fremgangsmaade til reduktion af monoklonale antistoffers heterogenitet | |
| FI925631A7 (fi) | Monoklonaaliset vasta-aineet | |
| DK65185D0 (da) | Fremgangsmaade til fremstilling af antistof | |
| DK98584A (da) | Fremgangsmaade til detektering af aendret dna | |
| DK610587A (da) | Analysemetode og -saet for antistof til hepatitis b-kerneantigen | |
| DK188185D0 (da) | Monoklonalt antistof | |
| DK14589D0 (da) | Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler | |
| DK319685D0 (da) | Monoklonale antistoffer, fremgangsmaade til frembringelse af antistofferne, hybridomaceller, der producerer antistofferne, og anvendelse af antistofferne | |
| DK409388D0 (da) | Fremgangsmaade til reduktion af ketoner | |
| DK388787A (da) | Fremgangsmaade til fremstilling af interferon | |
| DK147885D0 (da) | Fremgangsmaade til fremstilling af glycosidbindingrelateret antigen | |
| DK437087A (da) | Monoklont antistof til bestemmelse af humant glycoalbumin | |
| DK144485A (da) | Monoklonale antistoffer | |
| DK717888A (da) | Monoklonale antistoffer | |
| DK37785D0 (da) | Monoclonalt antistof | |
| DK0401657T3 (da) | Fremgangsmåde til C-terminal modificering af proteiner | |
| DK276185D0 (da) | Monoklonale antistoffer,fremgangsmaade til fremstilling af disse samt deres diagnostiske anvendelse | |
| DK212884A (da) | Fremgangsmaade til fremstilling af isoxazolylimidazolidinoner | |
| DK161570C (da) | Fremgangsmaade og apparat til korrugering af metalroer | |
| DK329685D0 (da) | Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalaninalkylestere | |
| DK413389D0 (da) | Monoklonale antistoffer | |
| DK338889A (da) | Fremgangsmaade til bestemmelse af antistoffer | |
| DK240286D0 (da) | Monoklonale antistoffer | |
| DK143389D0 (da) | Fremgangsmaade til fremstilling af 20-deoxotylosin | |
| DK49585A (da) | Fremgangsmaade til paavirkning af laeskehastigheden for braendt kalk og anvendelse af fremgangsmaaden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |